(Q42776144)

7 November 2017

title

Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study (English)

1 reference

7 November 2017

C Collin

1

1 reference

7 November 2017

V Boussaud

2

1 reference

7 November 2017

S Lefeuvre

3

1 reference

7 November 2017

C Amrein

4

1 reference

7 November 2017

A S Glouzman

5

1 reference

7 November 2017

L Havard

6

1 reference

7 November 2017

E M Billaud

7

1 reference

7 November 2017

R Guillemain

8

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

Transplantation Proceedings

7 November 2017

published in

1 reference

7 November 2017

volume

42

1 reference

7 November 2017

issue

10

1 reference

7 November 2017

page(s)

4331-4337

1 reference

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Overview of tacrolimus-based immunosuppression after heart or lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Study of the renal function in nonrenal organ transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Calcineurin nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Immunosuppressive drugs for kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Immunosuppression: evolution in practice and trends, 1994-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Effect of bile flow on the absorption of tacrolimus in liver allograft transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Health risks posed by use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Investigation of the release behavior of diethylhexyl phthalate from polyvinyl chloride tubing for intravenous administration based on HCO60

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Evaluation and analysis of exposure levels of di(2-ethylhexyl) phthalate from blood bags

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Oral toxicity of bis(2-ethylhexyl) phthalate during pregnancy and suckling in the Long-Evans rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Prevalence and treatment of diabetes in France: trends between 2000 and 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Sampling times for monitoring tacrolimus in stable adult liver transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Control of malabsorption in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Nitroglycerin spray rapidly improves pain in a patient with chronic painful diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Clinical application of the nitroglycerin lingual spray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Optimization of the immunosuppressive protocol after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Clinical pharmacokinetics of tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Tacrolimus (FK506) as primary immunosuppressant after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Tacrolimus-based immunosuppressive protocols in lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Alternatives to heart transplantation. Symposium of the "Treatment of End-stage Heart and Lung Failure" working group on October 22, 2005 in Munich.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Sublingual administration of tacrolimus in a renal transplant patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

A pilot study on sublingual administration of tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Drug disposition in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.126

10.1016/J.TRANSPROCEED.2010.09.126

7 January 2021

Identifiers

DOI

1 reference

7 November 2017

1 reference